REQUEST A DEMO
Total
USD $0.00
Search more companies

Janpi Medicina del Ser A Traves del Arte " S.A.S. (Ecuador)

Main Activities: Performing Arts Companies
Full name: Janpi Medicina del Ser A Traves del Arte " S.A.S. Profile Updated: June 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Janpi Medicina del Ser A Traves del Arte " S.A.S. is an enterprise based in Ecuador. Its main office is in Quito. It operates in the Performing Arts Companies industry. The company was established on June 23, 2022. There are currently 1 (2024) people employed by Janpi Medicina del Ser A Traves del Arte " S.A.S.. The company’s latest financial report indicates a net sales revenue drop of 78.69% in 2024. A growth of 54.38% was recorded in its total assets. The net profit margin of Janpi Medicina del Ser A Traves del Arte " S.A.S. increased by 14.97% in 2024.

Headquarters
Calle E14A, N494-34
Quito; Pichincha;

Contact Details: Purchase the Janpi Medicina del Ser A Traves del Arte " S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Janpi Medicina del Ser A Traves del Arte " S.A.S. report to view the information.
Registered Capital:
Purchase the Janpi Medicina del Ser A Traves del Arte " S.A.S. report to view the information.
Financial Auditors:
Purchase the Janpi Medicina del Ser A Traves del Arte " S.A.S. report to view the information.
Incorporation Date:
June 23, 2022
Key Executives
Purchase this report to view the information.
General Manager
Company Performance
Financial values in the chart are available after Janpi Medicina del Ser A Traves del Arte " S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-78.69%
Total operating revenue
-78.69%
Operating profit (EBIT)
32.3%
EBITDA
25.57%
Net Profit (Loss) for the Period
67.67%
Total Assets
54.38%
Total Equity
144.56%
Operating Profit Margin (ROS)
14.86%
Net Profit Margin
14.97%
Return on Equity (ROE)
-27.1%
Quick Ratio
2.63%
Cash Ratio
0.27%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?